Literature DB >> 2161128

Adverse drug effects on neuromuscular transmission.

J F Howard1.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2161128     DOI: 10.1055/s-2008-1041258

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


× No keyword cloud information.
  5 in total

1.  Investigation on the mechanism of exacerbation of myasthenia gravis by aminoglycoside antibiotics in mouse model.

Authors:  Changqin Liu; Fang Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  The sympathetic nervous system regulates skeletal muscle motor innervation and acetylcholine receptor stability.

Authors:  Anna C Z Rodrigues; Maria L Messi; Zhong-Min Wang; Martin C Abba; Andrea Pereyra; Alexander Birbrair; Tan Zhang; Meaghan O'Meara; Ping Kwan; Elsa I S Lopez; Monte S Willis; Akiva Mintz; D Clark Files; Cristina Furdui; Ronald W Oppenheim; Osvaldo Delbono
Journal:  Acta Physiol (Oxf)       Date:  2018-10-22       Impact factor: 6.311

3.  Impact of Topiramate on Rat Phrenic Nerve-Hemidiaphragm Preparations.

Authors:  Cem İsmail Küçükali; Erdem Tüzün; Asiye Nurten
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

Review 4.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 5.  Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment.

Authors:  Isin Baral Kulaksizoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.